M07.652 Enteropathic arthropathies, left hip

Name of the Condition

• Enteropathic arthropathies, left hip

Summary

Enteropathic arthropathies, left hip refers to joint inflammation affecting the left hip, associated with inflammatory bowel diseases (IBD) such as Crohn's disease or ulcerative colitis. The hip arthropathy often mirrors the activity of the underlying gastrointestinal condition, with symptoms potentially occurring before, during, or after IBD onset. This condition is considered an extraintestinal manifestation of IBD, where systemic inflammation drives joint involvement.

Causes

Enteropathic arthropathies, left hip are linked to the systemic inflammation characteristic of IBD. The exact mechanism is not fully understood, but immune-mediated processes are believed to play a role, where gut inflammation triggers joint inflammation. Shared inflammatory pathways and genetic factors between the gut and joints may contribute to the development of left hip involvement.

Risk Factors

• Active or chronic inflammatory bowel disease (Crohn's disease, ulcerative colitis).
• Family history of IBD or enteropathic arthropathy.
• Severity of gastrointestinal disease activity.
• Age: Onset often occurs in young to middle adulthood.

Symptoms

• Hip pain, swelling, and stiffness in the left hip.
• Reduced range of motion in the left hip joint.
• Symptoms may flare with IBD exacerbations.
• Morning stiffness lasting more than 30 minutes.
• Asymmetric joint involvement (left hip affected).

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history of IBD, and imaging studies (e.g., X-rays, MRI) to assess left hip joint inflammation. Laboratory tests may include inflammatory markers (e.g., ESR, CRP) and exclusion of other causes of hip pain. A rheumatologist or gastroenterologist may collaborate to confirm the association with IBD.

Treatment Options

Treatment focuses on managing both the joint and gastrointestinal symptoms. Nonsteroidal anti-inflammatory drugs (NSAIDs) may alleviate pain, while disease-modifying therapies for IBD (e.g., biologics) can reduce systemic inflammation. Physical therapy may improve hip mobility, and corticosteroid injections are sometimes used for acute flares. Surgery is rarely needed unless joint damage is severe.

Prognosis and Follow-Up

Prognosis depends on the control of underlying IBD. With effective treatment, joint symptoms often improve, but flares may occur with gastrointestinal disease activity. Regular follow-up with a rheumatologist and gastroenterologist is recommended to monitor joint function and adjust therapies as needed.

Complications

• Chronic hip pain or stiffness.
• Reduced mobility or gait abnormalities.
• Joint damage or degenerative changes over time.
• Impact on quality of life due to persistent symptoms.

Lifestyle & Prevention

• Maintain IBD remission through prescribed medications and lifestyle adjustments.
• Engage in low-impact exercises (e.g., swimming) to preserve hip mobility.
• Avoid activities that exacerbate hip pain.
• Monitor for symptom flares and report changes to healthcare providers promptly.

When to Seek Professional Help

Seek medical attention if you experience persistent left hip pain, swelling, or stiffness, especially if accompanied by IBD symptoms (e.g., diarrhea, abdominal pain) or if symptoms worsen despite home care.

Tips for Medical Coders

Document the specific joint involvement (left hip) and its association with IBD to support accurate coding. Ensure clinical notes specify the laterality (left) and confirm the enteropathic arthropathy diagnosis. Verify that the code aligns with the documented site and underlying condition.